The FDA in the US has approved Philosys' portable blood glucose monitor for Android-based smartphones, following an approval for iOS devices earlier this year. In a statement, the company said it was "pleased to be able to announce that our new device is now available on Google Play and will soon become available worldwide through all major mobile carriers." Increasing numbers of blood glucose monitors that interface with smartphones are hitting the market, with Dexcom receiving FDA approval for its app-based solution earlier this year.
The FDA in the US has approved Philosys' portable blood glucose monitor for Android-based smartphones, following an approval for iOS devices earlier this year. The Gmate Blood Glucose Monitoring System plugs into the device via the headphone jack, and communicates with a companion app, allowing diabetes sufferers to track the results of their glucose readings and communicate results to a medical professional. Increasing numbers of blood glucose monitors that interface with smartphones are hitting the market, with Dexcom receiving FDA approval for its app-based solution earlier this year.